NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT05091528 2022-08-18A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive CancersSilverback TherapeuticsPhase 1/2 Terminated2 enrolled 9 charts
NCT00758134 2013-05-29Trastuzumab Therapy in Non-Small Cell Lung Cancer PatientsIstituto Clinico HumanitasPhase 2 Terminated9 enrolled